PMC:7195088 / 60263-61274
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1803 | 118-126 | Species | denotes | patients | Tax:9606 |
1804 | 295-303 | Species | denotes | patients | Tax:9606 |
1805 | 309-319 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1806 | 504-512 | Species | denotes | patients | Tax:9606 |
1807 | 631-639 | Species | denotes | patients | Tax:9606 |
1808 | 1002-1010 | Species | denotes | patients | Tax:9606 |
1809 | 876-883 | Chemical | denotes | steroid | MESH:D013256 |
1810 | 948-955 | Chemical | denotes | steroid | MESH:D013256 |
1811 | 132-152 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1812 | 360-372 | Disease | denotes | inflammation | MESH:D007249 |
1813 | 394-405 | Disease | denotes | lung injury | MESH:D055370 |
1814 | 455-464 | Disease | denotes | pneumonia | MESH:D011014 |
1815 | 495-503 | Disease | denotes | COVID-19 | MESH:C000657245 |
1816 | 607-621 | Disease | denotes | critically ill | MESH:D016638 |
1817 | 622-630 | Disease | denotes | COVID-19 | MESH:C000657245 |
1818 | 645-649 | Disease | denotes | ARDS | MESH:D012128 |
1819 | 675-699 | Disease | denotes | ARDS respiratory failure | MESH:D012131 |
1820 | 974-992 | Disease | denotes | non–critically ill | MESH:D016638 |
1821 | 993-1001 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T95 | 377-385 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T96 | 394-398 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T49 | 394-398 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T101 | 455-464 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T102 | 680-699 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T344 | 132-140 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T345 | 143-152 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T346 | 309-317 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T347 | 360-372 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T348 | 399-405 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T349 | 455-464 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T350 | 495-503 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T351 | 622-630 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T352 | 645-649 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T353 | 675-679 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T354 | 680-699 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
T355 | 993-1001 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T332 | 174-186 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T333 | 394-398 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T334 | 394-398 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T7997 | 85-99 | Chemical | denotes | corticosteroid | http://purl.obolibrary.org/obo/CHEBI_50858 |
T21891 | 268-283 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T62412 | 588-603 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T11802 | 876-883 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
T65 | 948-955 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T29 | 360-372 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T441 | 0-153 | Sentence | denotes | So far, no definitive efficacy or effectiveness data are available on the benefit of corticosteroid administration in patients with SARS-CoV-2 infection. |
T442 | 154-320 | Sentence | denotes | As the World Health Organization underlines, there is an important need for efficacy data from RCT for supporting corticosteroids therapy in patients with SARS-CoV-2. |
T443 | 321-782 | Sentence | denotes | However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for the rapidly progressive pneumonia and clinical deterioration in COVID-19 patients [44,58,67], we suggest (expert opinion only) to consider administration of corticosteroids in critically ill COVID-19 patients with ARDS or with worsening of non-ARDS respiratory failure in the absence of bacterial/fungal superinfections (independent of ICU admission). |
T444 | 783-1011 | Sentence | denotes | However, in the absence of convincing evidence, the following cannot currently be supported: steroid administration stratified according to inflammatory markers and steroid administration in non–critically ill COVID-19 patients. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32360444-31986264-22369807 | 514-516 | 31986264 | denotes | 44 |
32360444-22088618-22369808 | 517-519 | 22088618 | denotes | 58 |
32360444-32192578-22369809 | 520-522 | 32192578 | denotes | 67 |